The Cigna Group Stock (NYSE:CI)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$260.87

52W Range

$239.51 - $350.00

50D Avg

$279.63

200D Avg

$289.42

Market Cap

$71.02B

Avg Vol (3M)

$1.70M

Beta

0.23

Div Yield

$6.09 (2.29%)

CI Company Profile


The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Show More

Industry

Medical - Healthcare Plans

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

71,295

IPO Date

Mar 31, 1982

Website

CI Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Cigna Healthcare$47.41B$47.53B-
Evernorth$234.95B$198.18B-
Network Pharmacy--$67.51B
Service--$12.62B
Product--$137.24B
Home Delivery And Specialty--$65.73B
Service, Other--$210.00M
Other Pharmacy--$9.05B

Fiscal year ends in Dec 25 | Currency in USD

CI Financial Summary


Dec 25Dec 24Dec 23
Revenue$274.95B$247.12B$195.26B
Operating Income$9.13B$9.42B$8.54B
Net Income$5.96B$3.43B$5.16B
EBITDA$12.17B$11.45B$10.85B
Basic EPS$22.30$12.25$17.57
Diluted EPS$22.17$12.12$17.39

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Feb 05, 26 | 8:30 AM
Q3 25Oct 30, 25 | 8:30 AM
Q2 25Jul 31, 25 | 8:30 AM

Peer Comparison


TickerCompany
REGNRegeneron Pharmaceuticals, Inc.
ELVElevance Health Inc.
HUMHumana Inc.
CORCencora, Inc.
CAHCardinal Health, Inc.
BDXBecton, Dickinson and Company
ZTSZoetis Inc.
CVSCVS Health Corporation
IDXXIDEXX Laboratories, Inc.
CNCCentene Corporation